{"id":353107,"date":"2026-11-18T15:37:49","date_gmt":"2026-11-18T10:07:49","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=353107"},"modified":"2026-11-18T15:37:49","modified_gmt":"2026-11-18T10:07:49","slug":"ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/","title":{"rendered":"3 Ports and Logistics Company, Drug Ingredients Maker and Naval Shipbuilder Stocks With a Strong Future Roadmap: Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E84;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders: ROE of 11.7% to 26.5% and FY22 to FY26 revenue CAGR of 9.2% to 23.2%. Prices as of 17 Nov 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E84;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The three <strong>port, drug ingredient and warship stocks<\/strong> to watch are <strong>Adani Ports and SEZ<\/strong>, <strong>Granules India<\/strong> and <strong>Mazagon Dock Shipbuilders<\/strong>. Their <strong>return on equity<\/strong> ranges from <strong>11.7% to 26.5%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 9.2% to 23.2%. Mazagon Dock Shipbuilders leads on both return on equity at 26.5% and revenue growth at 23.2% a year. Prices are based on the 17 November 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n<p>Port, drug ingredient and warship stocks give investors a way to track businesses that sit close to everyday demand in India. Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders cover a ports and logistics company, a drug ingredients maker and a naval shipbuilder.<\/p>\n<p>This list covers three port, drug ingredient and warship stocks with complete current figures: Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders. Every figure comes from the latest reported financials and the 17 November 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#What_Are_Port_Drug_Ingredient_and_Warship_Stocks\" title=\"What Are Port, Drug Ingredient and Warship Stocks?\">What Are Port, Drug Ingredient and Warship Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Port_Drug_Ingredient_and_Warship_Stocks_at_a_Glance\" title=\"Port, Drug Ingredient and Warship Stocks at a Glance\">Port, Drug Ingredient and Warship Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Why_Do_Port_Drug_Ingredient_and_Warship_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Port, Drug Ingredient and Warship Stocks Have a Strong Roadmap in India?\">Why Do Port, Drug Ingredient and Warship Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Why_Adani_Ports_and_SEZ_Features_Among_These_Port_Drug_Ingredient_and_Warship_Stocks\" title=\"Why Adani Ports and SEZ Features Among These Port, Drug Ingredient and Warship Stocks\">Why Adani Ports and SEZ Features Among These Port, Drug Ingredient and Warship Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Why_Granules_India_Features_Among_These_Port_Drug_Ingredient_and_Warship_Stocks\" title=\"Why Granules India Features Among These Port, Drug Ingredient and Warship Stocks\">Why Granules India Features Among These Port, Drug Ingredient and Warship Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Why_Mazagon_Dock_Shipbuilders_Features_Among_These_Port_Drug_Ingredient_and_Warship_Stocks\" title=\"Why Mazagon Dock Shipbuilders Features Among These Port, Drug Ingredient and Warship Stocks\">Why Mazagon Dock Shipbuilders Features Among These Port, Drug Ingredient and Warship Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Adani_Ports_and_SEZ_vs_Granules_India_vs_Mazagon_Dock_Shipbuilders_on_Key_Financials\" title=\"Adani Ports and SEZ vs Granules India vs Mazagon Dock Shipbuilders on Key Financials\">Adani Ports and SEZ vs Granules India vs Mazagon Dock Shipbuilders on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Key_Risks_to_Check_Before_Investing_in_Port_Drug_Ingredient_and_Warship_Stocks\" title=\"Key Risks to Check Before Investing in Port, Drug Ingredient and Warship Stocks\">Key Risks to Check Before Investing in Port, Drug Ingredient and Warship Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Final_Thoughts_on_Port_Drug_Ingredient_and_Warship_Stocks\" title=\"Final Thoughts on Port, Drug Ingredient and Warship Stocks\">Final Thoughts on Port, Drug Ingredient and Warship Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#What_are_port_drug_ingredient_and_warship_stocks\" title=\"What are port, drug ingredient and warship stocks?\">What are port, drug ingredient and warship stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Which_port_drug_ingredient_and_warship_stocks_are_covered_in_this_list\" title=\"Which port, drug ingredient and warship stocks are covered in this list?\">Which port, drug ingredient and warship stocks are covered in this list?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Why_do_port_drug_ingredient_and_warship_stocks_have_a_strong_future_roadmap_in_India\" title=\"Why do port, drug ingredient and warship stocks have a strong future roadmap in India?\">Why do port, drug ingredient and warship stocks have a strong future roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#How_has_Adani_Ports_and_SEZ_performed_financially\" title=\"How has Adani Ports and SEZ performed financially?\">How has Adani Ports and SEZ performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#How_has_Granules_India_performed_financially\" title=\"How has Granules India performed financially?\">How has Granules India performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#How_has_Mazagon_Dock_Shipbuilders_performed_financially\" title=\"How has Mazagon Dock Shipbuilders performed financially?\">How has Mazagon Dock Shipbuilders performed financially?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#What_risks_should_investors_check_before_buying_port_drug_ingredient_and_warship_stocks\" title=\"What risks should investors check before buying port, drug ingredient and warship stocks?\">What risks should investors check before buying port, drug ingredient and warship stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder-stocks-roadmap-steppeland-list\/#Is_this_list_of_port_drug_ingredient_and_warship_stocks_investment_advice\" title=\"Is this list of port, drug ingredient and warship stocks investment advice?\">Is this list of port, drug ingredient and warship stocks investment advice?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Port_Drug_Ingredient_and_Warship_Stocks\"><\/span><strong>What Are Port, Drug Ingredient and Warship Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Port, drug ingredient and warship stocks<\/strong> are listed companies that run ports, terminals and logistics services across India, make active drug ingredients and finished medicines, and build warships and submarines for the navy. Their earnings depend on cargo volumes, drug orders and defence orders.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Port_Drug_Ingredient_and_Warship_Stocks_at_a_Glance\"><\/span><strong>Port, Drug Ingredient and Warship Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE (%)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">D\/E<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/adaniports\/adani-ports-and-special-economic-zone-ltd-share-price-today\">Adani Ports and SEZ<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,917<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">404,621<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30.8<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.3<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.66<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/granules\/granules-india-ltd-share-price-today\">Granules India<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">815.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">22,002<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">33.2<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">36.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.7<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/mazdock\/mazagon-dock-shipbuilders-ltd-share-price-today\">Mazagon Dock Shipbuilders<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,847<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">82,854<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">29.0<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">48.1<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.5<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.05<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>On valuation, all three trade at a <strong>P\/E<\/strong> below their industry P\/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing port, drug ingredient and warship stocks should look at <strong>return on equity<\/strong> and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in port, drug ingredient and warship stocks can use the coming numbers to test whether growth is holding.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Port_Drug_Ingredient_and_Warship_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Port, Drug Ingredient and Warship Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Port, drug ingredient and warship stocks<\/strong> have a strong roadmap in India because rising cargo volumes, steady outsourcing of drug making and large naval building plans keep widening the market for these companies.<\/p>\n<ul>\n<li><strong>Ports.<\/strong> More trade moves through Indian terminals.<\/li>\n<li><strong>Drug ingredients.<\/strong> Pharma firms source from reliable plants.<\/li>\n<li><strong>Naval shipbuilding.<\/strong> The navy adds new vessels.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Why_Adani_Ports_and_SEZ_Features_Among_These_Port_Drug_Ingredient_and_Warship_Stocks\"><\/span><strong>Why Adani Ports and SEZ Features Among These Port, Drug Ingredient and Warship Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the port, drug ingredient and warship stocks on this list, Adani Ports and SEZ is India&#8217;s largest private port operator, handling containers, bulk cargo and liquids at multiple ports, and it also offers logistics services and marine operations.<\/p>\n<p>Revenue rose from Rs 19,343 crore in FY22 to Rs 40,854 crore in FY26, a compound annual growth rate of 20.6%. Net profit grew from Rs 4,953 crore in FY22 to Rs 12,782 crore in FY26, which works out to a compound annual growth rate of 26.7%.<\/p>\n<p>In the June 2026 quarter, revenue grew 23.9% year on year to Rs 11,674 crore, while net profit rose 10.2% to Rs 3,650 crore. The company has a return on equity of 13.3%, a debt to equity ratio of 0.66 and a <strong>market capitalisation<\/strong> of Rs 404,621 crore. The stock trades at a <strong>P\/E<\/strong> of 30.8, below the industry P\/E of 31.5.<\/p>\n<p><strong>Roadmap:<\/strong> The company is adding port capacity, rail-linked logistics and international terminals as trade volumes rise. Integrated services from port to inland logistics improve customer stickiness.<\/p>\n<p><strong>What to watch:<\/strong> Follow cargo volumes, new terminals and logistics revenue.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Granules_India_Features_Among_These_Port_Drug_Ingredient_and_Warship_Stocks\"><\/span><strong>Why Granules India Features Among These Port, Drug Ingredient and Warship Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the cargo terminals, API maker and naval yard shares on this list, Granules India is a Hyderabad-based pharmaceutical manufacturer that makes active ingredients, intermediates and finished dosage forms, with a strong position in paracetamol, metformin and ibuprofen.<\/p>\n<p>In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%.<\/p>\n<p>Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0.<\/p>\n<p><strong>Roadmap:<\/strong> The company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.<\/p>\n<p><strong>What to watch:<\/strong> Monitor new product approvals and the share of finished dosages in total sales.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Mazagon_Dock_Shipbuilders_Features_Among_These_Port_Drug_Ingredient_and_Warship_Stocks\"><\/span><strong>Why Mazagon Dock Shipbuilders Features Among These Port, Drug Ingredient and Warship Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the three companies on this list, Mazagon Dock Shipbuilders is a Mumbai-based defence shipyard that builds warships and submarines for the Indian Navy and also takes on ship repair and offshore work.<\/p>\n<p>The company has a return on equity of 26.5%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 82,854 crore. The stock trades at a P\/E of 29.0, below the industry P\/E of 48.1.<\/p>\n<p>Revenue rose from Rs 6,144 crore in FY22 to Rs 14,146 crore in FY26, a compound annual growth rate of 23.2%. Net profit grew from Rs 563 crore in FY22 to Rs 2,422 crore in FY26, which works out to a compound annual growth rate of 44.0%. In the June 2026 quarter, revenue grew 10.4% year on year to Rs 3,256 crore, while net profit rose 22.1% to Rs 512 crore.<\/p>\n<p><strong>Roadmap:<\/strong> The shipyard has a long order book of destroyers, frigates and submarines, and the multi-year build cycle gives revenue visibility. Capacity additions and a push towards indigenous submarine and warship programmes support its position as a core naval supplier.<\/p>\n<p><strong>What to watch:<\/strong> Monitor milestone-linked revenue on the big naval programmes and any fresh orders announced through the year.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Adani_Ports_and_SEZ_vs_Granules_India_vs_Mazagon_Dock_Shipbuilders_on_Key_Financials\"><\/span><strong>Adani Ports and SEZ vs Granules India vs Mazagon Dock Shipbuilders on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets the three port, drug ingredient and warship stocks side by side on revenue, profit and margin, using reported figures.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY22 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Revenue CAGR (FY22-FY26)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">FY26 Net Margin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Adani Ports and SEZ<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19,343<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">40,854<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.6%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">12,782<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">31.3%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Granules India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,783<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">5,386<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">595<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Mazagon Dock Shipbuilders<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6,144<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">14,146<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,422<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p>Mazagon Dock Shipbuilders posts the highest return on equity in this group at 26.5%. Adani Ports and SEZ has the largest FY26 revenue at Rs 40,854 crore, and Mazagon Dock Shipbuilders shows the fastest revenue growth with a 23.2% compound annual rate. A useful habit with <strong>port, drug ingredient and warship stocks<\/strong> is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several port operator, pharma ingredients and shipbuilding stocks instead of one name, which keeps a single result from deciding the outcome.<\/p>\n<p>The June 2026 quarter, the latest reported, gives a fresh read on momentum:<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY26 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Q1 FY27 Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Year-on-Year Growth<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Adani Ports and SEZ<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,422<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11,674<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">23.9%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Granules India<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,226<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,479<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">20.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Mazagon Dock Shipbuilders<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,949<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">3,256<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">10.4%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Check_Before_Investing_in_Port_Drug_Ingredient_and_Warship_Stocks\"><\/span><strong>Key Risks to Check Before Investing in Port, Drug Ingredient and Warship Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Every theme carries risks that deserve a check before any decision. For these port, drug ingredient and warship stocks, the main points are: Long-term cargo terminals, API maker and naval yard shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.<\/p>\n<ul>\n<li><strong>Cargo volumes.<\/strong> Freight and parcel volumes follow trade and consumption.<\/li>\n<li><strong>Regulatory approvals.<\/strong> Plant inspections and approvals can affect supplies.<\/li>\n<li><strong>Order timing.<\/strong> Defence and space orders can shift between periods.<\/li>\n<\/ul>\n<p>Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Use the Univest Stock Screener<\/a><\/strong> to filter port, drug ingredient and warship stocks by market capitalisation, P\/E, ROE and growth, and build your own shortlist.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Thoughts_on_Port_Drug_Ingredient_and_Warship_Stocks\"><\/span><strong>Final Thoughts on Port, Drug Ingredient and Warship Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Port, drug ingredient and warship stocks<\/strong> work best when investors track growth, valuation and return on equity side by side. Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders each have a clear plan to grow. Based on the 17 November 2026 close, Adani Ports and SEZ trades at Rs 1,917, Granules India at Rs 815.5 and Mazagon Dock Shipbuilders at Rs 1,847. Valuation matters as much as growth, so compare each company&#8217;s P\/E with its industry P\/E before adding any of these port, drug ingredient and warship stocks to a watchlist.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track port, drug ingredient and warship stocks, set price alerts and get research-backed stock ideas.<\/em><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h3><span class=\"ez-toc-section\" id=\"What_are_port_drug_ingredient_and_warship_stocks\"><\/span><strong>What are port, drug ingredient and warship stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Port, drug ingredient and warship stocks are listed companies that run ports, terminals and logistics services across India, make active drug ingredients and finished medicines, and build warships and submarines for the navy. Their earnings depend on cargo volumes, drug orders and defence orders. This list looks at three of them, Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_port_drug_ingredient_and_warship_stocks_are_covered_in_this_list\"><\/span><strong>Which port, drug ingredient and warship stocks are covered in this list?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This list covers Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders. Based on the 17 November 2026 close, Adani Ports and SEZ traded at Rs 1,917, Granules India at Rs 815.5 and Mazagon Dock Shipbuilders at Rs 1,847. Their return on equity ranges from <strong>11.7% to 26.5%<\/strong>, and their <strong>revenue compound annual growth<\/strong> from FY22 to FY26 ranges from 9.2% to 23.2%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_do_port_drug_ingredient_and_warship_stocks_have_a_strong_future_roadmap_in_India\"><\/span><strong>Why do port, drug ingredient and warship stocks have a strong future roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> <strong>Port, drug ingredient and warship stocks<\/strong> have a strong roadmap in India because rising cargo volumes, steady outsourcing of drug making and large naval building plans keep widening the market for these companies. The main drivers are as follows. Ports. More trade moves through Indian terminals. Drug ingredients. Pharma firms source from reliable plants. Naval shipbuilding. The navy adds new vessels. Together these factors give the companies on this list a visible path for growth over the coming years.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Adani_Ports_and_SEZ_performed_financially\"><\/span><strong>How has Adani Ports and SEZ performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 19,343 crore in FY22 to Rs 40,854 crore in FY26, a compound annual growth rate of 20.6%. Net profit grew from Rs 4,953 crore in FY22 to Rs 12,782 crore in FY26, which works out to a compound annual growth rate of 26.7%. In the June 2026 quarter, revenue grew 23.9% year on year to Rs 11,674 crore, while net profit rose 10.2% to Rs 3,650 crore. The company has a return on equity of 13.3%, a debt to equity ratio of 0.66 and a market capitalisation of Rs 404,621 crore. The stock trades at a P\/E of 30.8, below the industry P\/E of 31.5. Looking ahead, the company is adding port capacity, rail-linked logistics and international terminals as trade volumes rise. Integrated services from port to inland logistics improve customer stickiness.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Granules_India_performed_financially\"><\/span><strong>How has Granules India performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_has_Mazagon_Dock_Shipbuilders_performed_financially\"><\/span><strong>How has Mazagon Dock Shipbuilders performed financially?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose from Rs 6,144 crore in FY22 to Rs 14,146 crore in FY26, a compound annual growth rate of 23.2%. Net profit grew from Rs 563 crore in FY22 to Rs 2,422 crore in FY26, which works out to a compound annual growth rate of 44.0%. In the June 2026 quarter, revenue grew 10.4% year on year to Rs 3,256 crore, while net profit rose 22.1% to Rs 512 crore. The company has a return on equity of 26.5%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 82,854 crore. The stock trades at a P\/E of 29.0, below the industry P\/E of 48.1. Looking ahead, the shipyard has a long order book of destroyers, frigates and submarines, and the multi-year build cycle gives revenue visibility. Capacity additions and a push towards indigenous submarine and warship programmes support its position as a core naval supplier.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_risks_should_investors_check_before_buying_port_drug_ingredient_and_warship_stocks\"><\/span><strong>What risks should investors check before buying port, drug ingredient and warship stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should check a few risks before buying port, drug ingredient and warship stocks. Cargo volumes. Freight and parcel volumes follow trade and consumption. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_this_list_of_port_drug_ingredient_and_warship_stocks_investment_advice\"><\/span><strong>Is this list of port, drug ingredient and warship stocks investment advice?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are port, drug ingredient and warship stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Port, drug ingredient and warship stocks are listed companies that run ports, terminals and logistics services across India, make active drug ingredients and finished medicines, and build warships and submarines for the navy. Their earnings depend on cargo volumes, drug orders and defence orders. This list looks at three of them, Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders, using reported FY22 to FY26 financials and the 17 November 2026 closing prices.\"}},{\"@type\":\"Question\",\"name\":\"Which port, drug ingredient and warship stocks are covered in this list?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This list covers Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders. Based on the 17 November 2026 close, Adani Ports and SEZ traded at Rs 1,917, Granules India at Rs 815.5 and Mazagon Dock Shipbuilders at Rs 1,847. Their return on equity ranges from 11.7% to 26.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.2% to 23.2%.\"}},{\"@type\":\"Question\",\"name\":\"Why do port, drug ingredient and warship stocks have a strong future roadmap in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Port, drug ingredient and warship stocks have a strong roadmap in India because rising cargo volumes, steady outsourcing of drug making and large naval building plans keep widening the market for these companies. The main drivers are as follows. Ports. More trade moves through Indian terminals. Drug ingredients. Pharma firms source from reliable plants. Naval shipbuilding. The navy adds new vessels. Together these factors give the companies on this list a visible path for growth over the coming years.\"}},{\"@type\":\"Question\",\"name\":\"How has Adani Ports and SEZ performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 19,343 crore in FY22 to Rs 40,854 crore in FY26, a compound annual growth rate of 20.6%. Net profit grew from Rs 4,953 crore in FY22 to Rs 12,782 crore in FY26, which works out to a compound annual growth rate of 26.7%. In the June 2026 quarter, revenue grew 23.9% year on year to Rs 11,674 crore, while net profit rose 10.2% to Rs 3,650 crore. The company has a return on equity of 13.3%, a debt to equity ratio of 0.66 and a market capitalisation of Rs 404,621 crore. The stock trades at a P\/E of 30.8, below the industry P\/E of 31.5. Looking ahead, the company is adding port capacity, rail-linked logistics and international terminals as trade volumes rise. Integrated services from port to inland logistics improve customer stickiness.\"}},{\"@type\":\"Question\",\"name\":\"How has Granules India performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 3,783 crore in FY22 to Rs 5,386 crore in FY26, a compound annual growth rate of 9.2%. Net profit grew from Rs 413 crore in FY22 to Rs 595 crore in FY26, which works out to a compound annual growth rate of 9.6%. In the June 2026 quarter, revenue grew 20.6% year on year to Rs 1,479 crore, while net profit rose 59.8% to Rs 180 crore. The company has a return on equity of 11.7%, a debt to equity ratio of 0.30 and a market capitalisation of Rs 22,002 crore. The stock trades at a P\/E of 33.2, below the industry P\/E of 36.0. Looking ahead, the company is shifting its mix towards finished dosages, which earn better margins than ingredients, and it supplies customers in regulated markets, especially the United States. Capacity additions and new product approvals support steady growth.\"}},{\"@type\":\"Question\",\"name\":\"How has Mazagon Dock Shipbuilders performed financially?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose from Rs 6,144 crore in FY22 to Rs 14,146 crore in FY26, a compound annual growth rate of 23.2%. Net profit grew from Rs 563 crore in FY22 to Rs 2,422 crore in FY26, which works out to a compound annual growth rate of 44.0%. In the June 2026 quarter, revenue grew 10.4% year on year to Rs 3,256 crore, while net profit rose 22.1% to Rs 512 crore. The company has a return on equity of 26.5%, a debt to equity ratio of 0.05 and a market capitalisation of Rs 82,854 crore. The stock trades at a P\/E of 29.0, below the industry P\/E of 48.1. Looking ahead, the shipyard has a long order book of destroyers, frigates and submarines, and the multi-year build cycle gives revenue visibility. Capacity additions and a push towards indigenous submarine and warship programmes support its position as a core naval supplier.\"}},{\"@type\":\"Question\",\"name\":\"What risks should investors check before buying port, drug ingredient and warship stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors should check a few risks before buying port, drug ingredient and warship stocks. Cargo volumes. Freight and parcel volumes follow trade and consumption. Regulatory approvals. Plant inspections and approvals can affect supplies. Order timing. Defence and space orders can shift between periods. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.\"}},{\"@type\":\"Question\",\"name\":\"Is this list of port, drug ingredient and warship stocks investment advice?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No. This article is educational and uses publicly available data as of the 17 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Port, Drug Ingredient and Warship Stocks with a strong future roadmap: Adani Ports and SEZ, Granules India and Mazagon Dock Shipbuilders. Compare price, valuation, return on equity and revenue growth as of 17 November 2026.<\/p>\n","protected":false},"author":36,"featured_media":353104,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[8604,25843,3803,25114,25842,9050,2790,25844,20483],"class_list":["post-353107","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-adani-ports-and-sez","tag-api-maker-and-naval-yard-shares","tag-best-stocks","tag-cargo-terminals","tag-drug-ingredient-and-warship-stocks","tag-granules-india","tag-mazagon-dock-shipbuilders","tag-pharma-ingredients-and-shipbuilding-stocks","tag-port-operator"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["353104"],"rank_math_title":["Port, Drug Ingredient and Warship Stocks"],"rank_math_description":["Compare 3 port, drug ingredient and warship stocks with a strong future roadmap on CMP, market cap, P\/E, ROE and revenue growth. Data as of 17 Nov 2026."],"rank_math_focus_keyword":["port, drug ingredient and warship stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/3-ports-and-logistics-company-drug-ingredients-maker-and-naval-shipbuilder.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=353107"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353107\/revisions"}],"predecessor-version":[{"id":353108,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/353107\/revisions\/353108"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/353104"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=353107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=353107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=353107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}